Methods |
Study design: parallel RCT
Study time frame/recruitment period: October 1994 to April 1996
Follow‐up period: cumulative time of observation in the silver ring group was 857 months compared with 937 months in the control group
|
Participants |
Country: Germany
Setting: multicentre (7 sites)
All patients undergoing PD treatment
Number: treatment group (97); control group (98)
Mean age ± SD (years): treatment group (44.74 ± 17.6); control group (47.01 ± 18.5)
Sex (M/F): treatment group (63/34); control group (52/46)
Diabetic: treatment group (19/97); control group (21/98)
Exclusion criteria: acute or chronic exit‐site infections; sinus tract/tunnel infections; peritonitis during the ascertainment period (October 1994 to April 1995)
|
Interventions |
Treatment group
Control group
|
Outcomes |
First occurrence of exit‐site infection: exit‐site infection was defined as reddening with purulent discharge from the exit site (grade II of the visual classification scale) and/or a significantly increased sulcus fluid flow rate (SFFR) measurement in relation to the visual appearance of the exit site
First occurrence of peritonitis
Death (all causes)
Catheter removal/replacement
Technique failure
|
Notes |
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Insufficient information to permit judgement |
Allocation concealment (selection bias) |
Unclear risk |
Insufficient information to permit judgement |
Blinding of participants and personnel (performance bias)
All outcomes |
High risk |
Not blinded |
Blinding of outcome assessment (detection bias)
All outcomes |
Unclear risk |
Insufficient information to permit judgement |
Incomplete outcome data (attrition bias)
All outcomes |
High risk |
High dropout 30% (59/195) |
Selective reporting (reporting bias) |
Low risk |
Most of the outcomes were reported |
Other bias |
Unclear risk |
Insufficient information to permit judgement |